0
0
10/3/23 at 10:45am
Organization
PRNewswire
39 words
0
Comments
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and POINT Biopharma Global, Inc. (NASDAQ: PNT) today announced a definitive agreement for Lilly to acquire...
You are the first to view
https://www.prnewswire.com/news-releases/lilly-to-acquire-point-biopharma-to-expand-oncology-capabilities-into-next-generation-radioligand-therapies-301945243.html
Create an account
or login to join the discussion